TolaSure™
Search documents
BioMendics Brings New Hope for Epidermolysis Bullosa Simplex Patients as TAMES‑02 Trial Advances and JPM Week Approaches
Businesswire· 2026-01-06 13:45
ROOTSTOWN, Ohio--(BUSINESS WIRE)-- #Biotech--BioMendics advances its TAMES-02 trial of TolaSureâ"¢, a potential disease-modifying topical therapy for Epidermolysis Bullosa Simplex. ...
